nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2D6—breast cancer	0.257	1	CbGaD
Pyrimethamine—DHFR—Methotrexate—breast cancer	0.126	0.245	CbGbCtD
Pyrimethamine—CYP2C9—Anastrozole—breast cancer	0.0514	0.0996	CbGbCtD
Pyrimethamine—CYP2C8—Lapatinib—breast cancer	0.0491	0.0953	CbGbCtD
Pyrimethamine—CYP2C9—Idarubicin—breast cancer	0.0389	0.0755	CbGbCtD
Pyrimethamine—CYP2C8—Raloxifene—breast cancer	0.0372	0.0722	CbGbCtD
Pyrimethamine—CYP2D6—Idarubicin—breast cancer	0.0356	0.069	CbGbCtD
Pyrimethamine—CYP2C8—Tamoxifen—breast cancer	0.0246	0.0477	CbGbCtD
Pyrimethamine—CYP2C9—Capecitabine—breast cancer	0.0213	0.0414	CbGbCtD
Pyrimethamine—CYP2C8—Paclitaxel—breast cancer	0.0192	0.0371	CbGbCtD
Pyrimethamine—CYP2C8—Fluorouracil—breast cancer	0.0181	0.0352	CbGbCtD
Pyrimethamine—CYP2D6—Vinorelbine—breast cancer	0.0174	0.0337	CbGbCtD
Pyrimethamine—CYP2C9—Tamoxifen—breast cancer	0.0172	0.0333	CbGbCtD
Pyrimethamine—CYP2D6—Tamoxifen—breast cancer	0.0157	0.0304	CbGbCtD
Pyrimethamine—CYP2C9—Paclitaxel—breast cancer	0.0134	0.0259	CbGbCtD
Pyrimethamine—CYP2C9—Fluorouracil—breast cancer	0.0126	0.0245	CbGbCtD
Pyrimethamine—CYP2D6—Vinblastine—breast cancer	0.0107	0.0208	CbGbCtD
Pyrimethamine—CYP2D6—Doxorubicin—breast cancer	0.00658	0.0128	CbGbCtD
Pyrimethamine—Lamotrigine—SCN10A—breast cancer	0.00297	0.82	CrCbGaD
Pyrimethamine—Anaemia megaloblastic—Methotrexate—breast cancer	0.00193	0.0194	CcSEcCtD
Pyrimethamine—DHFR—nipple—breast cancer	0.00165	0.103	CbGeAlD
Pyrimethamine—DHFR—embryo—breast cancer	0.00136	0.0848	CbGeAlD
Pyrimethamine—Anaphylactic shock—Fluoxymesterone—breast cancer	0.00134	0.0134	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Letrozole—breast cancer	0.00123	0.0124	CcSEcCtD
Pyrimethamine—Pancytopenia—Ixabepilone—breast cancer	0.00119	0.012	CcSEcCtD
Pyrimethamine—Pancytopenia—Idarubicin—breast cancer	0.00107	0.0107	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Anastrozole—breast cancer	0.00105	0.0105	CcSEcCtD
Pyrimethamine—Leukopenia—Lapatinib—breast cancer	0.00104	0.0105	CcSEcCtD
Pyrimethamine—Erythema multiforme—Exemestane—breast cancer	0.00101	0.0101	CcSEcCtD
Pyrimethamine—DHFR—endometrium—breast cancer	0.000997	0.062	CbGeAlD
Pyrimethamine—CYP2C8—mammary gland—breast cancer	0.000991	0.0617	CbGeAlD
Pyrimethamine—Hypersensitivity—Fluoxymesterone—breast cancer	0.000985	0.00989	CcSEcCtD
Pyrimethamine—Leukopenia—Fulvestrant—breast cancer	0.000957	0.00961	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ixabepilone—breast cancer	0.000952	0.00956	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Lapatinib—breast cancer	0.000949	0.00953	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Chlorambucil—breast cancer	0.000949	0.00953	CcSEcCtD
Pyrimethamine—Leukopenia—Toremifene—breast cancer	0.000945	0.00949	CcSEcCtD
Pyrimethamine—DHFR—uterus—breast cancer	0.000919	0.0572	CbGeAlD
Pyrimethamine—Anorexia—Lapatinib—breast cancer	0.000905	0.00909	CcSEcCtD
Pyrimethamine—DHFR—pituitary gland—breast cancer	0.000903	0.0561	CbGeAlD
Pyrimethamine—DHFR—adipose tissue—breast cancer	0.000899	0.0559	CbGeAlD
Pyrimethamine—Erythema multiforme—Letrozole—breast cancer	0.000897	0.009	CcSEcCtD
Pyrimethamine—Erythema multiforme—Anastrozole—breast cancer	0.000897	0.009	CcSEcCtD
Pyrimethamine—CYP2C9—mammary gland—breast cancer	0.000881	0.0548	CbGeAlD
Pyrimethamine—Pancytopenia—Chlorambucil—breast cancer	0.000865	0.00869	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Toremifene—breast cancer	0.000844	0.00847	CcSEcCtD
Pyrimethamine—Anorexia—Fulvestrant—breast cancer	0.000832	0.00836	CcSEcCtD
Pyrimethamine—Leukopenia—Exemestane—breast cancer	0.000832	0.00835	CcSEcCtD
Pyrimethamine—DHFR—female reproductive system—breast cancer	0.000826	0.0514	CbGeAlD
Pyrimethamine—Decreased appetite—Lapatinib—breast cancer	0.000825	0.00829	CcSEcCtD
Pyrimethamine—Anorexia—Toremifene—breast cancer	0.000821	0.00825	CcSEcCtD
Pyrimethamine—DHFR—adrenal gland—breast cancer	0.000806	0.0501	CbGeAlD
Pyrimethamine—Stevens-Johnson syndrome—Chlorambucil—breast cancer	0.000805	0.00808	CcSEcCtD
Pyrimethamine—Pancytopenia—Vinblastine—breast cancer	0.000792	0.00796	CcSEcCtD
Pyrimethamine—Leukopenia—Ixabepilone—breast cancer	0.000785	0.00788	CcSEcCtD
Pyrimethamine—DHFR—bone marrow—breast cancer	0.00078	0.0485	CbGeAlD
Pyrimethamine—Pancytopenia—Tamoxifen—breast cancer	0.00077	0.00773	CcSEcCtD
Pyrimethamine—Decreased appetite—Fulvestrant—breast cancer	0.000759	0.00762	CcSEcCtD
Pyrimethamine—Pancytopenia—Melphalan—breast cancer	0.000754	0.00757	CcSEcCtD
Pyrimethamine—DHFR—female gonad—breast cancer	0.000752	0.0468	CbGeAlD
Pyrimethamine—Decreased appetite—Toremifene—breast cancer	0.000749	0.00752	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Exemestane—breast cancer	0.000742	0.00746	CcSEcCtD
Pyrimethamine—Leukopenia—Anastrozole—breast cancer	0.000739	0.00742	CcSEcCtD
Pyrimethamine—Leukopenia—Letrozole—breast cancer	0.000739	0.00742	CcSEcCtD
Pyrimethamine—Anorexia—Exemestane—breast cancer	0.000723	0.00726	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Tamoxifen—breast cancer	0.000717	0.0072	CcSEcCtD
Pyrimethamine—Leukopenia—Idarubicin—breast cancer	0.000701	0.00704	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Ixabepilone—breast cancer	0.0007	0.00703	CcSEcCtD
Pyrimethamine—Hypersensitivity—Lapatinib—breast cancer	0.000699	0.00702	CcSEcCtD
Pyrimethamine—DHFR—endocrine gland—breast cancer	0.000699	0.0435	CbGeAlD
Pyrimethamine—Erythema multiforme—Chlorambucil—breast cancer	0.000689	0.00692	CcSEcCtD
Pyrimethamine—Anorexia—Ixabepilone—breast cancer	0.000682	0.00685	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Anastrozole—breast cancer	0.000674	0.00677	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Letrozole—breast cancer	0.000674	0.00677	CcSEcCtD
Pyrimethamine—Decreased appetite—Exemestane—breast cancer	0.000659	0.00662	CcSEcCtD
Pyrimethamine—Pancytopenia—Vinorelbine—breast cancer	0.000659	0.00661	CcSEcCtD
Pyrimethamine—Haematuria—Goserelin—breast cancer	0.000658	0.00661	CcSEcCtD
Pyrimethamine—Lamotrigine—ABCB1—breast cancer	0.000652	0.18	CrCbGaD
Pyrimethamine—Hypersensitivity—Fulvestrant—breast cancer	0.000643	0.00646	CcSEcCtD
Pyrimethamine—Anorexia—Anastrozole—breast cancer	0.000642	0.00645	CcSEcCtD
Pyrimethamine—Anorexia—Letrozole—breast cancer	0.000642	0.00645	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Idarubicin—breast cancer	0.000639	0.00642	CcSEcCtD
Pyrimethamine—Pancytopenia—Thiotepa—breast cancer	0.000629	0.00632	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Raloxifene—breast cancer	0.000626	0.00629	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Idarubicin—breast cancer	0.000626	0.00629	CcSEcCtD
Pyrimethamine—Decreased appetite—Ixabepilone—breast cancer	0.000622	0.00625	CcSEcCtD
Pyrimethamine—Erythema multiforme—Tamoxifen—breast cancer	0.000614	0.00616	CcSEcCtD
Pyrimethamine—Anorexia—Idarubicin—breast cancer	0.000609	0.00612	CcSEcCtD
Pyrimethamine—Vomiting—Lapatinib—breast cancer	0.000603	0.00606	CcSEcCtD
Pyrimethamine—Decreased appetite—Letrozole—breast cancer	0.000586	0.00588	CcSEcCtD
Pyrimethamine—Decreased appetite—Anastrozole—breast cancer	0.000586	0.00588	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Gemcitabine—breast cancer	0.00058	0.00583	CcSEcCtD
Pyrimethamine—Leukopenia—Chlorambucil—breast cancer	0.000568	0.0057	CcSEcCtD
Pyrimethamine—Haematuria—Thiotepa—breast cancer	0.000563	0.00565	CcSEcCtD
Pyrimethamine—Hypersensitivity—Exemestane—breast cancer	0.000559	0.00561	CcSEcCtD
Pyrimethamine—Decreased appetite—Idarubicin—breast cancer	0.000556	0.00558	CcSEcCtD
Pyrimethamine—Vomiting—Fulvestrant—breast cancer	0.000555	0.00557	CcSEcCtD
Pyrimethamine—Vomiting—Toremifene—breast cancer	0.000548	0.0055	CcSEcCtD
Pyrimethamine—Pancytopenia—Mitoxantrone—breast cancer	0.000543	0.00545	CcSEcCtD
Pyrimethamine—Pancytopenia—Gemcitabine—breast cancer	0.000529	0.00531	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ixabepilone—breast cancer	0.000527	0.00529	CcSEcCtD
Pyrimethamine—Leukopenia—Vinblastine—breast cancer	0.00052	0.00523	CcSEcCtD
Pyrimethamine—Pancytopenia—Fluorouracil—breast cancer	0.00052	0.00522	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Chlorambucil—breast cancer	0.000507	0.00509	CcSEcCtD
Pyrimethamine—Leukopenia—Tamoxifen—breast cancer	0.000506	0.00508	CcSEcCtD
Pyrimethamine—Hypersensitivity—Anastrozole—breast cancer	0.000496	0.00498	CcSEcCtD
Pyrimethamine—CYP2C8—endometrium—breast cancer	0.000495	0.0308	CbGeAlD
Pyrimethamine—Leukopenia—Melphalan—breast cancer	0.000495	0.00497	CcSEcCtD
Pyrimethamine—Anorexia—Chlorambucil—breast cancer	0.000494	0.00496	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Gemcitabine—breast cancer	0.000492	0.00495	CcSEcCtD
Pyrimethamine—Haematuria—Mitoxantrone—breast cancer	0.000486	0.00488	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Paclitaxel—breast cancer	0.000486	0.00488	CcSEcCtD
Pyrimethamine—DHFR—lymph node—breast cancer	0.000483	0.0301	CbGeAlD
Pyrimethamine—Leukopenia—Goserelin—breast cancer	0.000483	0.00485	CcSEcCtD
Pyrimethamine—Vomiting—Exemestane—breast cancer	0.000482	0.00484	CcSEcCtD
Pyrimethamine—Haematuria—Gemcitabine—breast cancer	0.000474	0.00476	CcSEcCtD
Pyrimethamine—Hypersensitivity—Idarubicin—breast cancer	0.000471	0.00473	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vinblastine—breast cancer	0.000465	0.00467	CcSEcCtD
Pyrimethamine—Vomiting—Ixabepilone—breast cancer	0.000455	0.00457	CcSEcCtD
Pyrimethamine—Anorexia—Vinblastine—breast cancer	0.000452	0.00454	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Melphalan—breast cancer	0.000451	0.00453	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Tamoxifen—breast cancer	0.000451	0.00453	CcSEcCtD
Pyrimethamine—Decreased appetite—Chlorambucil—breast cancer	0.00045	0.00452	CcSEcCtD
Pyrimethamine—CYP2C8—pituitary gland—breast cancer	0.000448	0.0279	CbGeAlD
Pyrimethamine—Pancytopenia—Paclitaxel—breast cancer	0.000443	0.00445	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Melphalan—breast cancer	0.000442	0.00444	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Goserelin—breast cancer	0.00044	0.00442	CcSEcCtD
Pyrimethamine—Anorexia—Tamoxifen—breast cancer	0.000439	0.00441	CcSEcCtD
Pyrimethamine—Leukopenia—Vinorelbine—breast cancer	0.000433	0.00434	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Goserelin—breast cancer	0.000431	0.00433	CcSEcCtD
Pyrimethamine—Anorexia—Melphalan—breast cancer	0.00043	0.00432	CcSEcCtD
Pyrimethamine—Vomiting—Anastrozole—breast cancer	0.000428	0.0043	CcSEcCtD
Pyrimethamine—Vomiting—Letrozole—breast cancer	0.000428	0.0043	CcSEcCtD
Pyrimethamine—Erythema multiforme—Gemcitabine—breast cancer	0.000422	0.00423	CcSEcCtD
Pyrimethamine—Anorexia—Goserelin—breast cancer	0.00042	0.00422	CcSEcCtD
Pyrimethamine—Leukopenia—Thiotepa—breast cancer	0.000413	0.00415	CcSEcCtD
Pyrimethamine—Decreased appetite—Vinblastine—breast cancer	0.000413	0.00414	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Paclitaxel—breast cancer	0.000412	0.00414	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Docetaxel—breast cancer	0.000412	0.00414	CcSEcCtD
Pyrimethamine—CYP2C8—female reproductive system—breast cancer	0.00041	0.0255	CbGeAlD
Pyrimethamine—Vomiting—Idarubicin—breast cancer	0.000407	0.00408	CcSEcCtD
Pyrimethamine—Vomiting—Raloxifene—breast cancer	0.000407	0.00408	CcSEcCtD
Pyrimethamine—Decreased appetite—Tamoxifen—breast cancer	0.000401	0.00402	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Capecitabine—breast cancer	0.000399	0.00401	CcSEcCtD
Pyrimethamine—Haematuria—Paclitaxel—breast cancer	0.000397	0.00398	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Vinorelbine—breast cancer	0.000394	0.00396	CcSEcCtD
Pyrimethamine—Decreased appetite—Melphalan—breast cancer	0.000392	0.00394	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Vinorelbine—breast cancer	0.000386	0.00388	CcSEcCtD
Pyrimethamine—Decreased appetite—Goserelin—breast cancer	0.000383	0.00384	CcSEcCtD
Pyrimethamine—Hypersensitivity—Chlorambucil—breast cancer	0.000382	0.00383	CcSEcCtD
Pyrimethamine—Anorexia—Vinorelbine—breast cancer	0.000376	0.00378	CcSEcCtD
Pyrimethamine—Pancytopenia—Docetaxel—breast cancer	0.000375	0.00377	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Thiotepa—breast cancer	0.000369	0.0037	CcSEcCtD
Pyrimethamine—CYP2C9—female reproductive system—breast cancer	0.000364	0.0227	CbGeAlD
Pyrimethamine—Pancytopenia—Capecitabine—breast cancer	0.000364	0.00365	CcSEcCtD
Pyrimethamine—Anorexia—Thiotepa—breast cancer	0.000359	0.00361	CcSEcCtD
Pyrimethamine—Leukopenia—Irinotecan—breast cancer	0.000357	0.00358	CcSEcCtD
Pyrimethamine—Leukopenia—Mitoxantrone—breast cancer	0.000357	0.00358	CcSEcCtD
Pyrimethamine—Erythema multiforme—Paclitaxel—breast cancer	0.000353	0.00355	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vinblastine—breast cancer	0.00035	0.00351	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Docetaxel—breast cancer	0.000349	0.00351	CcSEcCtD
Pyrimethamine—Leukopenia—Gemcitabine—breast cancer	0.000347	0.00349	CcSEcCtD
Pyrimethamine—CYP2C8—endocrine gland—breast cancer	0.000347	0.0216	CbGeAlD
Pyrimethamine—Decreased appetite—Vinorelbine—breast cancer	0.000343	0.00344	CcSEcCtD
Pyrimethamine—Leukopenia—Fluorouracil—breast cancer	0.000342	0.00343	CcSEcCtD
Pyrimethamine—Hypersensitivity—Tamoxifen—breast cancer	0.00034	0.00341	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Capecitabine—breast cancer	0.000338	0.0034	CcSEcCtD
Pyrimethamine—Hypersensitivity—Melphalan—breast cancer	0.000333	0.00334	CcSEcCtD
Pyrimethamine—Vomiting—Chlorambucil—breast cancer	0.000329	0.00331	CcSEcCtD
Pyrimethamine—Decreased appetite—Thiotepa—breast cancer	0.000327	0.00329	CcSEcCtD
Pyrimethamine—Haematuria—Capecitabine—breast cancer	0.000325	0.00327	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Irinotecan—breast cancer	0.000325	0.00327	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Mitoxantrone—breast cancer	0.000325	0.00327	CcSEcCtD
Pyrimethamine—Hypersensitivity—Goserelin—breast cancer	0.000324	0.00326	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Irinotecan—breast cancer	0.000318	0.0032	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Mitoxantrone—breast cancer	0.000318	0.0032	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Gemcitabine—breast cancer	0.000317	0.00318	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Fluorouracil—breast cancer	0.000312	0.00313	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gemcitabine—breast cancer	0.00031	0.00312	CcSEcCtD
Pyrimethamine—Anorexia—Irinotecan—breast cancer	0.00031	0.00311	CcSEcCtD
Pyrimethamine—Anorexia—Mitoxantrone—breast cancer	0.00031	0.00311	CcSEcCtD
Pyrimethamine—CYP2C9—endocrine gland—breast cancer	0.000308	0.0192	CbGeAlD
Pyrimethamine—Thrombocytopenia—Fluorouracil—breast cancer	0.000305	0.00306	CcSEcCtD
Pyrimethamine—Anorexia—Gemcitabine—breast cancer	0.000302	0.00303	CcSEcCtD
Pyrimethamine—Vomiting—Vinblastine—breast cancer	0.000302	0.00303	CcSEcCtD
Pyrimethamine—Erythema multiforme—Docetaxel—breast cancer	0.000299	0.00301	CcSEcCtD
Pyrimethamine—Anorexia—Fluorouracil—breast cancer	0.000297	0.00298	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Methotrexate—breast cancer	0.000297	0.00298	CcSEcCtD
Pyrimethamine—Vomiting—Tamoxifen—breast cancer	0.000293	0.00294	CcSEcCtD
Pyrimethamine—Leukopenia—Paclitaxel—breast cancer	0.000291	0.00292	CcSEcCtD
Pyrimethamine—Hypersensitivity—Vinorelbine—breast cancer	0.000291	0.00292	CcSEcCtD
Pyrimethamine—Erythema multiforme—Capecitabine—breast cancer	0.00029	0.00291	CcSEcCtD
Pyrimethamine—Vomiting—Melphalan—breast cancer	0.000287	0.00288	CcSEcCtD
Pyrimethamine—Decreased appetite—Mitoxantrone—breast cancer	0.000283	0.00284	CcSEcCtD
Pyrimethamine—Decreased appetite—Irinotecan—breast cancer	0.000283	0.00284	CcSEcCtD
Pyrimethamine—Vomiting—Goserelin—breast cancer	0.00028	0.00281	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.000278	0.00279	CcSEcCtD
Pyrimethamine—Hypersensitivity—Thiotepa—breast cancer	0.000277	0.00279	CcSEcCtD
Pyrimethamine—Decreased appetite—Gemcitabine—breast cancer	0.000275	0.00277	CcSEcCtD
Pyrimethamine—CYP2D6—female reproductive system—breast cancer	0.000273	0.017	CbGeAlD
Pyrimethamine—Decreased appetite—Fluorouracil—breast cancer	0.000271	0.00272	CcSEcCtD
Pyrimethamine—Pancytopenia—Methotrexate—breast cancer	0.000271	0.00272	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Paclitaxel—breast cancer	0.000265	0.00266	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Paclitaxel—breast cancer	0.00026	0.00261	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000257	0.00258	CcSEcCtD
Pyrimethamine—Pancytopenia—Epirubicin—breast cancer	0.000253	0.00254	CcSEcCtD
Pyrimethamine—Anorexia—Paclitaxel—breast cancer	0.000253	0.00254	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000252	0.00253	CcSEcCtD
Pyrimethamine—Vomiting—Vinorelbine—breast cancer	0.000251	0.00252	CcSEcCtD
Pyrimethamine—CYP2D6—female gonad—breast cancer	0.000249	0.0155	CbGeAlD
Pyrimethamine—Leukopenia—Docetaxel—breast cancer	0.000247	0.00248	CcSEcCtD
Pyrimethamine—Haematuria—Methotrexate—breast cancer	0.000242	0.00243	CcSEcCtD
Pyrimethamine—Hypersensitivity—Mitoxantrone—breast cancer	0.00024	0.00241	CcSEcCtD
Pyrimethamine—Hypersensitivity—Irinotecan—breast cancer	0.00024	0.00241	CcSEcCtD
Pyrimethamine—Vomiting—Thiotepa—breast cancer	0.000239	0.0024	CcSEcCtD
Pyrimethamine—Leukopenia—Capecitabine—breast cancer	0.000239	0.0024	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000236	0.00237	CcSEcCtD
Pyrimethamine—Pancytopenia—Doxorubicin—breast cancer	0.000234	0.00235	CcSEcCtD
Pyrimethamine—CYP2D6—endocrine gland—breast cancer	0.000231	0.0144	CbGeAlD
Pyrimethamine—Decreased appetite—Paclitaxel—breast cancer	0.000231	0.00232	CcSEcCtD
Pyrimethamine—Hypersensitivity—Fluorouracil—breast cancer	0.00023	0.0023	CcSEcCtD
Pyrimethamine—Haematuria—Epirubicin—breast cancer	0.000227	0.00228	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Docetaxel—breast cancer	0.000225	0.00226	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Docetaxel—breast cancer	0.00022	0.00221	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000218	0.00219	CcSEcCtD
Pyrimethamine—Erythema multiforme—Methotrexate—breast cancer	0.000216	0.00217	CcSEcCtD
Pyrimethamine—Anorexia—Docetaxel—breast cancer	0.000214	0.00215	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Capecitabine—breast cancer	0.000213	0.00214	CcSEcCtD
Pyrimethamine—Haematuria—Doxorubicin—breast cancer	0.00021	0.00211	CcSEcCtD
Pyrimethamine—Anorexia—Capecitabine—breast cancer	0.000207	0.00208	CcSEcCtD
Pyrimethamine—Vomiting—Irinotecan—breast cancer	0.000207	0.00208	CcSEcCtD
Pyrimethamine—Vomiting—Mitoxantrone—breast cancer	0.000207	0.00208	CcSEcCtD
Pyrimethamine—Erythema multiforme—Epirubicin—breast cancer	0.000202	0.00203	CcSEcCtD
Pyrimethamine—Vomiting—Gemcitabine—breast cancer	0.000201	0.00202	CcSEcCtD
Pyrimethamine—Vomiting—Fluorouracil—breast cancer	0.000198	0.00199	CcSEcCtD
Pyrimethamine—Decreased appetite—Docetaxel—breast cancer	0.000195	0.00196	CcSEcCtD
Pyrimethamine—Hypersensitivity—Paclitaxel—breast cancer	0.000195	0.00196	CcSEcCtD
Pyrimethamine—Decreased appetite—Capecitabine—breast cancer	0.000189	0.0019	CcSEcCtD
Pyrimethamine—Erythema multiforme—Doxorubicin—breast cancer	0.000187	0.00188	CcSEcCtD
Pyrimethamine—Leukopenia—Methotrexate—breast cancer	0.000178	0.00178	CcSEcCtD
Pyrimethamine—Vomiting—Paclitaxel—breast cancer	0.000169	0.00169	CcSEcCtD
Pyrimethamine—Leukopenia—Epirubicin—breast cancer	0.000166	0.00167	CcSEcCtD
Pyrimethamine—Hypersensitivity—Docetaxel—breast cancer	0.000166	0.00166	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Methotrexate—breast cancer	0.000162	0.00163	CcSEcCtD
Pyrimethamine—Hypersensitivity—Capecitabine—breast cancer	0.00016	0.00161	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Methotrexate—breast cancer	0.000159	0.00159	CcSEcCtD
Pyrimethamine—Anorexia—Methotrexate—breast cancer	0.000154	0.00155	CcSEcCtD
Pyrimethamine—Leukopenia—Doxorubicin—breast cancer	0.000154	0.00155	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Epirubicin—breast cancer	0.000152	0.00152	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Epirubicin—breast cancer	0.000148	0.00149	CcSEcCtD
Pyrimethamine—Anorexia—Epirubicin—breast cancer	0.000145	0.00145	CcSEcCtD
Pyrimethamine—Vomiting—Docetaxel—breast cancer	0.000143	0.00144	CcSEcCtD
Pyrimethamine—Decreased appetite—Methotrexate—breast cancer	0.000141	0.00141	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Doxorubicin—breast cancer	0.00014	0.00141	CcSEcCtD
Pyrimethamine—Vomiting—Capecitabine—breast cancer	0.000138	0.00139	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Doxorubicin—breast cancer	0.000137	0.00138	CcSEcCtD
Pyrimethamine—Anorexia—Doxorubicin—breast cancer	0.000134	0.00134	CcSEcCtD
Pyrimethamine—Decreased appetite—Epirubicin—breast cancer	0.000132	0.00132	CcSEcCtD
Pyrimethamine—Decreased appetite—Doxorubicin—breast cancer	0.000122	0.00123	CcSEcCtD
Pyrimethamine—Hypersensitivity—Methotrexate—breast cancer	0.000119	0.0012	CcSEcCtD
Pyrimethamine—Hypersensitivity—Epirubicin—breast cancer	0.000112	0.00112	CcSEcCtD
Pyrimethamine—Hypersensitivity—Doxorubicin—breast cancer	0.000103	0.00104	CcSEcCtD
Pyrimethamine—Vomiting—Methotrexate—breast cancer	0.000103	0.00103	CcSEcCtD
Pyrimethamine—Vomiting—Epirubicin—breast cancer	9.64e-05	0.000968	CcSEcCtD
Pyrimethamine—Vomiting—Doxorubicin—breast cancer	8.92e-05	0.000896	CcSEcCtD
Pyrimethamine—CYP2C8—Metabolism—GSTA4—breast cancer	1.48e-05	0.000138	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDH7A1—breast cancer	1.48e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDH1A1—breast cancer	1.48e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.46e-05	0.000136	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.46e-05	0.000136	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.45e-05	0.000135	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX2—breast cancer	1.44e-05	0.000134	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA2—breast cancer	1.44e-05	0.000134	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CD—breast cancer	1.44e-05	0.000134	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NME1—breast cancer	1.43e-05	0.000133	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADSL—breast cancer	1.43e-05	0.000133	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—FHL2—breast cancer	1.43e-05	0.000133	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PHGDH—breast cancer	1.43e-05	0.000133	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—UMPS—breast cancer	1.43e-05	0.000133	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SULT1A1—breast cancer	1.43e-05	0.000133	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX4—breast cancer	1.43e-05	0.000133	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALB—breast cancer	1.42e-05	0.000132	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NME1—breast cancer	1.42e-05	0.000132	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—FHL2—breast cancer	1.42e-05	0.000132	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADSL—breast cancer	1.42e-05	0.000132	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—UMPS—breast cancer	1.42e-05	0.000132	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PHGDH—breast cancer	1.42e-05	0.000132	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN1B—breast cancer	1.4e-05	0.00013	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HPSE—breast cancer	1.4e-05	0.00013	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—BRIP1—breast cancer	1.4e-05	0.00013	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LDHB—breast cancer	1.4e-05	0.00013	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA1—breast cancer	1.39e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—IDH1—breast cancer	1.39e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HPSE—breast cancer	1.39e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—BRIP1—breast cancer	1.39e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LDHB—breast cancer	1.39e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NAT2—breast cancer	1.38e-05	0.000128	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NOS3—breast cancer	1.36e-05	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCC1—breast cancer	1.33e-05	0.000124	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA3—breast cancer	1.33e-05	0.000124	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMMR—breast cancer	1.33e-05	0.000124	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CTNNB1—breast cancer	1.32e-05	0.000123	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA3—breast cancer	1.32e-05	0.000123	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMMR—breast cancer	1.32e-05	0.000123	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCC1—breast cancer	1.32e-05	0.000123	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CDKN1A—breast cancer	1.29e-05	0.00012	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTEN—breast cancer	1.29e-05	0.00012	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.29e-05	0.00012	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARGC1B—breast cancer	1.28e-05	0.000119	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CB—breast cancer	1.25e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.24e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.24e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.24e-05	0.000116	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—breast cancer	1.24e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CA9—breast cancer	1.22e-05	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA4—breast cancer	1.22e-05	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MED12—breast cancer	1.21e-05	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—DPYD—breast cancer	1.21e-05	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CA9—breast cancer	1.21e-05	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA4—breast cancer	1.21e-05	0.000112	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SRC—breast cancer	1.2e-05	0.000111	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.19e-05	0.000111	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALDOA—breast cancer	1.19e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA2—breast cancer	1.18e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX2—breast cancer	1.18e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.18e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA2—breast cancer	1.17e-05	0.000109	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX2—breast cancer	1.17e-05	0.000109	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX4—breast cancer	1.17e-05	0.000109	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SULT1A1—breast cancer	1.17e-05	0.000109	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX4—breast cancer	1.16e-05	0.000108	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SULT1A1—breast cancer	1.16e-05	0.000108	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—STAT3—breast cancer	1.15e-05	0.000107	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA3—breast cancer	1.15e-05	0.000107	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC2A2—breast cancer	1.15e-05	0.000107	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—IDH1—breast cancer	1.14e-05	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA1—breast cancer	1.14e-05	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA1—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—IDH1—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NAT2—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CPT1A—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTR—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG2—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NAT2—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAPK3—breast cancer	1.1e-05	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HPGDS—breast cancer	1.1e-05	0.000102	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HBA1—breast cancer	1.09e-05	0.000102	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTEN—breast cancer	1.08e-05	0.000101	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MYC—breast cancer	1.07e-05	9.98e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—breast cancer	1.07e-05	9.96e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTT1—breast cancer	1.07e-05	9.92e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ACHE—breast cancer	1.07e-05	9.92e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGFR—breast cancer	1.05e-05	9.76e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.01e-05	9.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP17A1—breast cancer	1.01e-05	9.39e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS1—breast cancer	1e-05	9.3e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ENO1—breast cancer	1e-05	9.3e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	9.96e-06	9.27e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KRAS—breast cancer	9.92e-06	9.22e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MED12—breast cancer	9.91e-06	9.21e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—DPYD—breast cancer	9.91e-06	9.21e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	9.84e-06	9.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—DPYD—breast cancer	9.82e-06	9.13e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MED12—breast cancer	9.82e-06	9.13e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2D6—breast cancer	9.81e-06	9.12e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALDOA—breast cancer	9.75e-06	9.07e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDOA—breast cancer	9.67e-06	8.99e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA2—breast cancer	9.63e-06	8.95e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA3—breast cancer	9.47e-06	8.81e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC2A2—breast cancer	9.4e-06	8.74e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA3—breast cancer	9.39e-06	8.73e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—FASN—breast cancer	9.34e-06	8.68e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC2A2—breast cancer	9.32e-06	8.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—BCHE—breast cancer	9.3e-06	8.65e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	9.23e-06	8.58e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTR—breast cancer	9.21e-06	8.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CPT1A—breast cancer	9.21e-06	8.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG2—breast cancer	9.21e-06	8.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC5A5—breast cancer	9.18e-06	8.54e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTR—breast cancer	9.13e-06	8.49e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CPT1A—breast cancer	9.13e-06	8.49e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG2—breast cancer	9.13e-06	8.49e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CA—breast cancer	9.11e-06	8.47e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HPGDS—breast cancer	9.03e-06	8.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HBA1—breast cancer	8.98e-06	8.35e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HPGDS—breast cancer	8.96e-06	8.33e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HBA1—breast cancer	8.9e-06	8.28e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC2A1—breast cancer	8.87e-06	8.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NQO1—breast cancer	8.87e-06	8.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ACHE—breast cancer	8.76e-06	8.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTT1—breast cancer	8.76e-06	8.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTT1—breast cancer	8.69e-06	8.08e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ACHE—breast cancer	8.69e-06	8.08e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	8.69e-06	8.08e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP3A4—breast cancer	8.65e-06	8.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	8.61e-06	8e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1B1—breast cancer	8.5e-06	7.91e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HRAS—breast cancer	8.43e-06	7.84e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HSP90AA1—breast cancer	8.34e-06	7.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP17A1—breast cancer	8.29e-06	7.71e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP17A1—breast cancer	8.22e-06	7.65e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS1—breast cancer	8.21e-06	7.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ENO1—breast cancer	8.21e-06	7.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ENO1—breast cancer	8.14e-06	7.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS1—breast cancer	8.14e-06	7.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA1—breast cancer	8.11e-06	7.54e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.11e-06	7.54e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—breast cancer	8.07e-06	7.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.01e-06	7.44e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—STK11—breast cancer	8e-06	7.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP19A1—breast cancer	8e-06	7.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2D6—breast cancer	7.98e-06	7.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA2—breast cancer	7.9e-06	7.35e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA2—breast cancer	7.84e-06	7.29e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—FASN—breast cancer	7.67e-06	7.13e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—BCHE—breast cancer	7.63e-06	7.1e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CA—breast cancer	7.63e-06	7.09e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—FASN—breast cancer	7.6e-06	7.07e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—BCHE—breast cancer	7.57e-06	7.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC5A5—breast cancer	7.54e-06	7.01e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.51e-06	6.98e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC5A5—breast cancer	7.47e-06	6.95e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—breast cancer	7.44e-06	6.92e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—COMT—breast cancer	7.43e-06	6.91e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTP1—breast cancer	7.4e-06	6.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMOX1—breast cancer	7.3e-06	6.78e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NQO1—breast cancer	7.28e-06	6.77e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC2A1—breast cancer	7.28e-06	6.77e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ITPR1—breast cancer	7.28e-06	6.77e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC2A1—breast cancer	7.22e-06	6.71e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NQO1—breast cancer	7.22e-06	6.71e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP3A4—breast cancer	7.1e-06	6.6e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.07e-06	6.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP3A4—breast cancer	7.04e-06	6.55e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7e-06	6.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCB1—breast cancer	7e-06	6.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1B1—breast cancer	6.98e-06	6.49e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1B1—breast cancer	6.92e-06	6.44e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TYMS—breast cancer	6.88e-06	6.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSP90AA1—breast cancer	6.85e-06	6.37e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOR1—breast cancer	6.8e-06	6.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLA2G4A—breast cancer	6.8e-06	6.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—breast cancer	6.8e-06	6.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSP90AA1—breast cancer	6.79e-06	6.31e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA1—breast cancer	6.66e-06	6.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA1—breast cancer	6.6e-06	6.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—STK11—breast cancer	6.56e-06	6.1e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP19A1—breast cancer	6.56e-06	6.1e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX1—breast cancer	6.51e-06	6.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—STK11—breast cancer	6.51e-06	6.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP19A1—breast cancer	6.51e-06	6.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1A1—breast cancer	6.44e-06	5.99e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ERCC2—breast cancer	6.39e-06	5.94e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—breast cancer	6.23e-06	5.8e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.11e-06	5.68e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—COMT—breast cancer	6.1e-06	5.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTP1—breast cancer	6.07e-06	5.65e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—COMT—breast cancer	6.05e-06	5.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTP1—breast cancer	6.02e-06	5.6e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTHFR—breast cancer	6.01e-06	5.59e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMOX1—breast cancer	5.99e-06	5.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ITPR1—breast cancer	5.98e-06	5.56e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMOX1—breast cancer	5.94e-06	5.52e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ITPR1—breast cancer	5.92e-06	5.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCB1—breast cancer	5.75e-06	5.35e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCB1—breast cancer	5.7e-06	5.3e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TYMS—breast cancer	5.65e-06	5.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TYMS—breast cancer	5.6e-06	5.2e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOR1—breast cancer	5.58e-06	5.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLA2G4A—breast cancer	5.58e-06	5.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—breast cancer	5.58e-06	5.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CAV1—breast cancer	5.54e-06	5.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—breast cancer	5.53e-06	5.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOR1—breast cancer	5.53e-06	5.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLA2G4A—breast cancer	5.53e-06	5.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX1—breast cancer	5.34e-06	4.97e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX1—breast cancer	5.3e-06	4.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.29e-06	4.92e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1A1—breast cancer	5.29e-06	4.92e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ERCC2—breast cancer	5.25e-06	4.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1A1—breast cancer	5.25e-06	4.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ERCC2—breast cancer	5.2e-06	4.84e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CG—breast cancer	5.05e-06	4.69e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTHFR—breast cancer	4.93e-06	4.59e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTHFR—breast cancer	4.89e-06	4.55e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CAV1—breast cancer	4.55e-06	4.23e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CAV1—breast cancer	4.51e-06	4.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CD—breast cancer	4.44e-06	4.13e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALB—breast cancer	4.38e-06	4.07e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.31e-06	4.01e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NOS3—breast cancer	4.19e-06	3.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CG—breast cancer	4.14e-06	3.85e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CG—breast cancer	4.11e-06	3.82e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CB—breast cancer	3.87e-06	3.6e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—breast cancer	3.83e-06	3.56e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CD—breast cancer	3.64e-06	3.39e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CD—breast cancer	3.61e-06	3.36e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALB—breast cancer	3.6e-06	3.34e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALB—breast cancer	3.57e-06	3.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NOS3—breast cancer	3.44e-06	3.2e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NOS3—breast cancer	3.41e-06	3.17e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTEN—breast cancer	3.34e-06	3.11e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CB—breast cancer	3.18e-06	2.95e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CB—breast cancer	3.15e-06	2.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—breast cancer	3.15e-06	2.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—breast cancer	3.12e-06	2.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTEN—breast cancer	2.74e-06	2.55e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTEN—breast cancer	2.72e-06	2.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CA—breast cancer	2.36e-06	2.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.94e-06	1.8e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—breast cancer	1.93e-06	1.79e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.92e-06	1.78e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—breast cancer	1.58e-06	1.47e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—breast cancer	1.57e-06	1.46e-05	CbGpPWpGaD
